Pfizer

PFE NYSE
Overview Stats Financials News

Yahoo Finance • a day ago

Billionaires Are Buying These High-Yield Dividend Stocks Left and Right. Should You Follow Their Lead?

Are you famous enough for picking great stocks to become a billionaire money manager? If not, then there's a lot you could learn from the handful of folks who have. It's easier than ever for individuals to invest alongside the professiona... Full story

Yahoo Finance • 3 days ago

European Patent Office Sides with Moderna In COVID-19 Vaccine Patent Dispute With Pfizer/BioNTech

European Patent Office Sides with Moderna In COVID-19 Vaccine Patent Dispute With Pfizer/BioNTech Moderna Inc (NASDAQ:MRNA) has reportedly achieved a significant victory at the European Patent Office (EPO) in its ongoing legal battle with... Full story

Yahoo Finance • 5 days ago

3 No-Brainer Stocks to Buy With $500 Right Now

Over the long run, the stock market has proved to be a superior wealth creator. Though commodities like gold and oil, along with housing and Treasury bonds, have produced positive nominal returns for investors, none of these other asset cl... Full story

Yahoo Finance • 10 days ago

Stocks Surge On Healthy Earnings Season, Rising Jobless Claims: This Week In The Markets

Stocks Surge On Healthy Earnings Season, Rising Jobless Claims: This Week In The Markets It's been a quiet week in the markets, marked by a dearth of major economic news and a consistent flow of positive indicators from the first-quarter... Full story

Yahoo Finance • 10 days ago

Decoding Pfizer Inc (PFE): A Strategic SWOT Insight

Strengths highlight Pfizer's robust product portfolio and global market presence. Weaknesses underscore the challenges in revenue fluctuations and patent expirations. Opportunities emphasize potential growth in emerging markets and R&D adv... Full story

Yahoo Finance • 13 days ago

15 Best S&P 500 Dividend Stocks To Buy Now

In this article, we discuss 15 best S&P 500 dividend stocks to buy now. You can skip our detailed analysis of dividend stocks in the S&P 500 and their past performance, and go directly to read 5 Best S&P 500 Dividend Stocks To Buy Now. It... Full story

Yahoo Finance • 15 days ago

3 No-Brainer Stocks to Buy in May

Don't believe the adage to "sell in May and go away." Buying stocks can still be a smart move, especially if you're a long-term investor. Three Motley Fool contributors have identified stocks they think are no-brainers to buy in May. Here... Full story

Yahoo Finance • 18 days ago

My Top 5 Favorite High-Yield Dividend Stocks to Buy in May

The adage "sell in May and go away" hasn't always been wise advice. It's especially impractical for income investors who need to have their money working for them. Instead of selling stocks in May, income investors could be better off buyi... Full story

Yahoo Finance • 20 days ago

5 Top Stocks to Buy in May

Earnings season is officially here. As per usual, there have already been epic sell-offs and run-ups across well-known names. However, long-term investors know that the best way to view a quarterly earnings report is within the context of... Full story

Yahoo Finance • 20 days ago

Forget Nvidia: Prominent Billionaires Are Selling It and Buying These 2 Ultra-High-Yield Dividend Stocks Instead

Since the advent of the internet roughly 30 years ago, there hasn't been an innovation or trend that's excited professional and everyday investors quite like artificial intelligence (AI). The lure of AI is the ability of software and syst... Full story

Yahoo Finance • 21 days ago

TIVDAK® (tisotumab vedotin-tftv) Receives U.S. FDA Approval to Treat Recurrent or Metastatic Cervical Cancer

Genmab A/S Company Announcement Full approval based on global Phase 3 study demonstrating overall survival benefit of TIVDAK compared to chemotherapy TIVDAK is the first antibody-drug conjugate in this patient population to have positive... Full story

Yahoo Finance • 21 days ago

FDA Grants Full Approval for TIVDAK® to Treat Recurrent or Metastatic Cervical Cancer

TIVDAK is the first antibody-drug conjugate (ADC) to have positive overall survival data for patients with previously treated recurrent or metastatic cervical cancer Conversion to full approval from accelerated approval is based on positiv... Full story

Yahoo Finance • 21 days ago

mRNA Is Promising A Breakthrough In Fighting Cancer

mRNA Is Promising A Breakthrough In Fighting Cancer When it comes to cancer, there’s innovation both on the diagnostics and the treatment front thanks to messenger RNA, or mRNA, a genetic material we all got acquainted with during the COV... Full story

Yahoo Finance • 22 days ago

3 High-Yield Dividend Stocks That Could Soar 22% to 49%, According to Wall Street

Income investors can be growth investors, too. Granted, it's not always easy to find stocks that pay generous dividends and offer solid prospects of share price appreciation. However, such stocks exist. Here are three high-yield dividend s... Full story

Yahoo Finance • 23 days ago

3 Dividend Stocks to Buy and Hold for the Next Decade

Buy, hold, rake in solid income. That sounds like a pretty good investing strategy. You only have to find the right stocks worthy of holding for the long term and that pay attractive dividends. Three Motley Fool contributors think they ca... Full story

Yahoo Finance • 24 days ago

Want $2,000 in Annual Dividends? Invest $30,000 in These 3 Stocks

"If you don't find a way to make money while you sleep, you will work until you die." That's a quote from billionaire investor Warren Buffett which emphasizes the importance of making your money work for you. By generating income without h... Full story

Yahoo Finance • a month ago

13 Best Ethical Companies to Invest in 2024

In this piece, we will take a look at the 13 best ethical companies to invest in 2024. If you want to skip our overview of ESG stocks, then you can take a look at 5 Best Ethical Companies to Invest in 2024. The relationship of the corpora... Full story

Yahoo Finance • a month ago

European Commission Approves Pfizer’s EMBLAVEO® for Patients with Multidrug-Resistant Infections and Limited Treatment Options

EMBLAVEO® is the first β-lactam/β-lactamase inhibitor antibiotic combination approved in the European Union for treating serious infections in adult patients caused by multidrug-resistant Gram-negative bacteria, including metallo-β-lactama... Full story

Yahoo Finance • a month ago

11 Best Low Price Pharma Stocks To Invest In

In this piece, we will take a look at the 13 best low price pharma stocks to invest in. If you want to skip our overview of the pharma industry and want to skip to the five top low price stocks in this list, then you can skip ahead to 5 Be... Full story

Yahoo Finance • a month ago

3 Stocks Under $50 You Can Buy Hand Over Fist Right Now

Investing isn't just for the wealthy. Sure, it takes money to make money. However, it doesn't take much money to start making money investing in stocks. Of course, you still must find great companies to buy. That's not a difficult task, t... Full story